Background: The detection of Pneumocystis jirovecii DNA in respiratory specimen from individuals who do not have signs or symptoms of pneumonia has been defined as colonization. The role of P. jirovecii colonization in the development or progression of various lung diseases has been reported, but little information about P. jirovecii colonization in patients is available in the People's Republic of China.
Objective: To determine the prevalence of P. jirovecii colonization in patients with various pulmonary diseases, including the acute and stable stage of COPD, interstitial lung diseases, cystic fibrosis, and chronic bronchiectasis.
Materials And Methods: A loop-mediated isothermal amplification (LAMP) and a conventional polymerase chain reaction (PCR) method for detecting P. jirovecii were developed. Ninety-eight HIV-negative patients who were followed-up and who had undergone bronchoscopy for diagnosis of various underlying respiratory diseases were included in the study. Sputa of these patients were analyzed with LAMP amplification of P. jirovecii gene. In addition, conventional PCR, Giemsa and Gomori's methenamine silver nitrate staining assays were applied to all specimens.
Results: The sensitivity and specificity test showed that there was no cross-reaction with other fungi or bacteria in detecting the specific gene of P. jirovecii by LAMP, and the minimum detection limits by LAMP was 50 copies/mL. P. jirovecii DNA was detected in 62 of 98 (63.3%) sputa specimens by LAMP assay and 22.45% (22/98) by conventional PCR. However, no P. jirovecii cysts were found by Giemsa and Gomori's methenamine silver nitrate in all of gene-positive specimens.
Conclusion: The results of our study showed that prevalence of P. jirovecii colonization is particularly high in patients with chronic pulmonary diseases in the People's Republic of China, and the LAMP method is better for evaluation of the colonization of P. jirovecii in sputum specimen than conventional PCR.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598221 | PMC |
| http://dx.doi.org/10.2147/COPD.S89666 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Analysis of Mutations in Dihydropteroate Synthase and Dihydropteroate Reductase Genes Among Non-HIV Patients in China.
Infect Drug Resist
December 2024
Beijing Institute of Tropical Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Purpose: pneumonia (PJP) shows a high fatality rate in non-HIV patients. However, there are limited data on drug resistance-related gene mutations in these patients. This study aimed to describe the prevalence of mutations in the dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) genes of in non-HIV patients in China, providing a reference for drug usage.
View Article and Find Full Text PDFVariable reliability of the (1,3)-β-d-glucan test for screening Pneumocystis pneumonia in HIV-negative patients depending on the underlying condition.
Med Mycol
November 2024
Laboratoire de Parasitologie et Mycologie, Centre de Biologie Humaine, CHU Amiens-Picardie, 80054 Amiens, France.
Article Synopsis
- The (1,3)-β-d-Glucan (BG) assay is a non-invasive diagnostic test for invasive fungal diseases, particularly Pneumocystis pneumonia (PCP), but its effectiveness varies in HIV-negative patients with hematological malignancies.
- A study from 2009 to 2021 involving 55 PCP patients and 61 colonized patients revealed that BG levels were significantly higher in PCP patients, showing 85% sensitivity and 82% specificity for diagnosing PCP.
- The BG assay was especially reliable in non-cancer patients (100% sensitivity), while those with solid (72%) or hematological cancers (79%) had lower sensitivity, highlighting the need to consider underlying health conditions when using BG results
Quantitative real time PCR for distinction between infection/colonization in hospitalized patients.
Front Cell Infect Microbiol
October 2024
Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Background: Identification of the opportunistic fungus in respiratory specimens presents challenges, particularly in differentiating between colonization and active infection. The present study assessed a probe-based real time PCR (qPCR) diagnostic effectiveness in patients with diverse underlying conditions, particularly those with COVID-19 and pulmonary insufficiency.
Methods: To set up the qPCR, clinical samples from 281 patients with respiratory ailments were tested.
Increased risk of Pneumocystis jirovecii colonization in rheumatoid arthritis patients on biologics and Janus kinase inhibitor.
J Microbiol Immunol Infect
September 2024
Department of Internal Medicine, Division of Allergy, Immunology, and Rheumatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address:
Background: The prevalence of Pneumocystis jirovecii (PJ) pneumonia among rheumatic patients is rising. PJ colonization serves as a reservoir for transmission and precedes the development of PJ pneumonia. We aim to clarify the association of PJ colonization in patients of rheumatoid arthritis (RA) treated with biologics or Janus kinase inhibitors (JAKi).
View Article and Find Full Text PDFDescription, clinical impact and early outcome of S. maltophilia respiratory tract infections after lung transplantation, A retrospective observational study.
Respir Med Res
November 2024
Service de Pneumologie et Transplantation Pulmonaire, Hôpitaux Saint-Joseph et Marie-Lannelongue, 133 avenue de la Résistance, 92350 Le Plessis-Robinson, France; Université Paris-Saclay, Faculté de Médecine, 63 rue Gabriel Péri, 94270 Le Kremlin Bicêtre, France; INSERM UMR_S 999, Hôpital Marie Lannelongue, 133 avenue de la Résistance, 92350 Le Plessis-Robinson, France.
Background And Research Question: S. maltophilia infections are associated with significant morbidity and mortality. Little is known regarding its presentation, management, and outcome in lung transplant recipients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!